Psychotic symptoms and ayahuasca: a case report

Detalhes bibliográficos
Autor(a) principal: Gios, Thaísa Silva
Data de Publicação: 2016
Outros Autores: Pinheiro, Maria Carolina Pedalino, Calfat, Elie Leal de Barros
Tipo de documento: Artigo
Idioma: por
Título da fonte: Debates em Psiquiatria (Online)
Texto Completo: https://revistardp.org.br/revista/article/view/141
Resumo: Hallucinogens are chemical agents that induce changes in perception, thinking, and emotions. One natural hallucinogen is ayahuasca, originally used in the Amazon by indigenous tribes, prepared as a mixture of two plants: Banisteriopsis caapi, which contains beta-carbolines, an inhibitor of monoamine oxidase (MAO), and Psychotria viridis, rich in N,N-dimethyltryptamine (DMT), which actson serotonergic receptors. Currently, the use of ayahuasca tea has spread to different regions of the world, and some religions, such as Brazilian denominations União do Vegetal, Santo Daime, and Barquinha, use the tea in their rituals. This study reports on a case of psychotic symptoms and ayahuasca use. A young woman was admitted for social isolation, poor self-care, and bizarre delusions starting 3 years ago, with gradual worsening. She was a member of União do Vegetal and made frequent use of ayahuasca. During hospitalization, she was diagnosed with schizophrenia, and improved after electroconvulsivetherapy. Recent research shows that clinical manifestations of hallucinogens resemble those of schizophrenia. Therefore, pharmacological experiments with hallucinogens are often used as models of psychosis.
id ABP-2_6d931a940d89497b4900d259b7cd9ad1
oai_identifier_str oai:ojs.emnuvens.com.br:article/141
network_acronym_str ABP-2
network_name_str Debates em Psiquiatria (Online)
repository_id_str
spelling Psychotic symptoms and ayahuasca: a case reportSintomatologia psicótica e ayahuasca: relato de casoBanisteriopsisNN-dimetiltriptaminatranstornos psicóticosBanisteriopsisNN-dimetiltriptaminepsychotic disordersHallucinogens are chemical agents that induce changes in perception, thinking, and emotions. One natural hallucinogen is ayahuasca, originally used in the Amazon by indigenous tribes, prepared as a mixture of two plants: Banisteriopsis caapi, which contains beta-carbolines, an inhibitor of monoamine oxidase (MAO), and Psychotria viridis, rich in N,N-dimethyltryptamine (DMT), which actson serotonergic receptors. Currently, the use of ayahuasca tea has spread to different regions of the world, and some religions, such as Brazilian denominations União do Vegetal, Santo Daime, and Barquinha, use the tea in their rituals. This study reports on a case of psychotic symptoms and ayahuasca use. A young woman was admitted for social isolation, poor self-care, and bizarre delusions starting 3 years ago, with gradual worsening. She was a member of União do Vegetal and made frequent use of ayahuasca. During hospitalization, she was diagnosed with schizophrenia, and improved after electroconvulsivetherapy. Recent research shows that clinical manifestations of hallucinogens resemble those of schizophrenia. Therefore, pharmacological experiments with hallucinogens are often used as models of psychosis.Alucinógenos são agentes químicos que induzem alterações na percepção, no pensamento e nas emoções. Entre os alucinógenos naturais há a ayahuasca, originalmente utilizada por tribos indígenas da Amazônia, preparada com a mistura de duas plantas: Banisteriopsis caapi, que contém β-carbolinas, um inibidor da monoamina oxidase (MAO), e Psychotria viridis, rica em N,N-dimetiltriptamina (DMT), que atua nos receptores serotoninérgicos. Atualmente, o uso do chá de ayahuasca se espalhou por diversas regiões do mundo, e diferentes religiões, tais como União do Vegetal, Santo Daime e Barquinha, fazem seu uso ritualístico. Este estudo relata um caso sobre sintomatologia psicótica e uso da ayahuasca. Trata-se de uma paciente jovem, admitida por quadro de isolamento social, prejuízo do autocuidado e delírio bizarro, iniciado há 3 anos, com piora gradual. Era membra da União do Vegetal e fazia uso frequente de ayahuasca. Durante a internação, foi feito o diagnóstico de esquizofrenia, e a paciente melhorou com eletroconvulsoterapia. Pesquisas recentes demonstram que as manifestações clínicas dos alucinógenos se assemelham às da esquizofrenia. Por isso, experimentos farmacológicos com alucinógenos são rrequentemente usados como modelos de psicose.Associação Brasileira de Psiquiatria2016-04-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado pelos paresapplication/pdfhttps://revistardp.org.br/revista/article/view/14110.25118/2236-918X-6-2-5Debates in Psychiatry; Vol. 6 No. 2 (2016); 38-41Debates em Psiquiatria; Vol. 6 Núm. 2 (2016); 38-41Debates em Psiquiatria; v. 6 n. 2 (2016); 38-412763-90372236-918Xreponame:Debates em Psiquiatria (Online)instname:Associação Brasileira de Psiquiatria (ABP)instacron:ABPporhttps://revistardp.org.br/revista/article/view/141/123https://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessGios, Thaísa SilvaPinheiro, Maria Carolina PedalinoCalfat, Elie Leal de Barros2023-06-03T22:23:29Zoai:ojs.emnuvens.com.br:article/141Revistahttps://revistardp.org.br/revista/oaiPUBhttps://revistardp.org.br/revista/oairdp@abp.org.br2763-90372236-918Xopendoar:2023-06-03T22:23:29Debates em Psiquiatria (Online) - Associação Brasileira de Psiquiatria (ABP)false
dc.title.none.fl_str_mv Psychotic symptoms and ayahuasca: a case report
Sintomatologia psicótica e ayahuasca: relato de caso
title Psychotic symptoms and ayahuasca: a case report
spellingShingle Psychotic symptoms and ayahuasca: a case report
Gios, Thaísa Silva
Banisteriopsis
N
N-dimetiltriptamina
transtornos psicóticos
Banisteriopsis
N
N-dimetiltriptamine
psychotic disorders
title_short Psychotic symptoms and ayahuasca: a case report
title_full Psychotic symptoms and ayahuasca: a case report
title_fullStr Psychotic symptoms and ayahuasca: a case report
title_full_unstemmed Psychotic symptoms and ayahuasca: a case report
title_sort Psychotic symptoms and ayahuasca: a case report
author Gios, Thaísa Silva
author_facet Gios, Thaísa Silva
Pinheiro, Maria Carolina Pedalino
Calfat, Elie Leal de Barros
author_role author
author2 Pinheiro, Maria Carolina Pedalino
Calfat, Elie Leal de Barros
author2_role author
author
dc.contributor.author.fl_str_mv Gios, Thaísa Silva
Pinheiro, Maria Carolina Pedalino
Calfat, Elie Leal de Barros
dc.subject.por.fl_str_mv Banisteriopsis
N
N-dimetiltriptamina
transtornos psicóticos
Banisteriopsis
N
N-dimetiltriptamine
psychotic disorders
topic Banisteriopsis
N
N-dimetiltriptamina
transtornos psicóticos
Banisteriopsis
N
N-dimetiltriptamine
psychotic disorders
description Hallucinogens are chemical agents that induce changes in perception, thinking, and emotions. One natural hallucinogen is ayahuasca, originally used in the Amazon by indigenous tribes, prepared as a mixture of two plants: Banisteriopsis caapi, which contains beta-carbolines, an inhibitor of monoamine oxidase (MAO), and Psychotria viridis, rich in N,N-dimethyltryptamine (DMT), which actson serotonergic receptors. Currently, the use of ayahuasca tea has spread to different regions of the world, and some religions, such as Brazilian denominations União do Vegetal, Santo Daime, and Barquinha, use the tea in their rituals. This study reports on a case of psychotic symptoms and ayahuasca use. A young woman was admitted for social isolation, poor self-care, and bizarre delusions starting 3 years ago, with gradual worsening. She was a member of União do Vegetal and made frequent use of ayahuasca. During hospitalization, she was diagnosed with schizophrenia, and improved after electroconvulsivetherapy. Recent research shows that clinical manifestations of hallucinogens resemble those of schizophrenia. Therefore, pharmacological experiments with hallucinogens are often used as models of psychosis.
publishDate 2016
dc.date.none.fl_str_mv 2016-04-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistardp.org.br/revista/article/view/141
10.25118/2236-918X-6-2-5
url https://revistardp.org.br/revista/article/view/141
identifier_str_mv 10.25118/2236-918X-6-2-5
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistardp.org.br/revista/article/view/141/123
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
dc.source.none.fl_str_mv Debates in Psychiatry; Vol. 6 No. 2 (2016); 38-41
Debates em Psiquiatria; Vol. 6 Núm. 2 (2016); 38-41
Debates em Psiquiatria; v. 6 n. 2 (2016); 38-41
2763-9037
2236-918X
reponame:Debates em Psiquiatria (Online)
instname:Associação Brasileira de Psiquiatria (ABP)
instacron:ABP
instname_str Associação Brasileira de Psiquiatria (ABP)
instacron_str ABP
institution ABP
reponame_str Debates em Psiquiatria (Online)
collection Debates em Psiquiatria (Online)
repository.name.fl_str_mv Debates em Psiquiatria (Online) - Associação Brasileira de Psiquiatria (ABP)
repository.mail.fl_str_mv rdp@abp.org.br
_version_ 1796798364774301696